251 related articles for article (PubMed ID: 23135160)
1. Modulation of feeding by chronic rAAV expression of a relaxin-3 peptide agonist in rat hypothalamus.
Ganella DE; Callander GE; Ma S; Bye CR; Gundlach AL; Bathgate RA
Gene Ther; 2013 Jul; 20(7):703-16. PubMed ID: 23135160
[TBL] [Abstract][Full Text] [Related]
2. Partial agonist activity of R3(BΔ23-27)R/I5 at RXFP3--investigation of in vivo and in vitro pharmacology.
Kristensson L; Mayer G; Ploj K; Wetterlund M; Arlbrandt S; Björquist A; Wissing BM; Castaldo M; Larsson N
Eur J Pharmacol; 2015 Jan; 747():123-31. PubMed ID: 25496752
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of oxytocin and vasopressin neuron activity in rat hypothalamic paraventricular nucleus by relaxin-3-RXFP3 signalling.
Kania A; Gugula A; Grabowiecka A; de Ávila C; Blasiak T; Rajfur Z; Lewandowski MH; Hess G; Timofeeva E; Gundlach AL; Blasiak A
J Physiol; 2017 Jun; 595(11):3425-3447. PubMed ID: 28098344
[TBL] [Abstract][Full Text] [Related]
4. Development of a selective agonist for relaxin family peptide receptor 3.
Wei D; Hu MJ; Shao XX; Wang JH; Nie WH; Liu YL; Xu ZG; Guo ZY
Sci Rep; 2017 Jun; 7(1):3230. PubMed ID: 28607363
[TBL] [Abstract][Full Text] [Related]
5. Increased feeding and body weight gain in rats after acute and chronic activation of RXFP3 by relaxin-3 and receptor-selective peptides: functional and therapeutic implications.
Ganella DE; Ryan PJ; Bathgate RA; Gundlach AL
Behav Pharmacol; 2012 Sep; 23(5-6):516-25. PubMed ID: 22854307
[TBL] [Abstract][Full Text] [Related]
6. Relaxin-3 mRNA levels in nucleus incertus correlate with alcohol and sucrose intake in rats.
Ryan PJ; Krstew EV; Sarwar M; Gundlach AL; Lawrence AJ
Drug Alcohol Depend; 2014 Jul; 140():8-16. PubMed ID: 24837581
[TBL] [Abstract][Full Text] [Related]
7. Exploring receptor selectivity of the chimeric relaxin family peptide R3/I5 by incorporating unnatural amino acids.
Wang JH; Hu MJ; Zhang L; Shao XX; Lv CH; Liu YL; Xu ZG; Guo ZY
Biochimie; 2018 Nov; 154():77-85. PubMed ID: 30102931
[TBL] [Abstract][Full Text] [Related]
8. The structural and functional role of the B-chain C-terminal arginine in the relaxin-3 peptide antagonist, R3(BDelta23-27)R/I5.
Hossain MA; Bathgate RA; Rosengren KJ; Shabanpoor F; Zhang S; Lin F; Tregear GW; Wade JD
Chem Biol Drug Des; 2009 Jan; 73(1):46-52. PubMed ID: 19152634
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of relaxin-3 and a selective relaxin-3 receptor agonist on food and water intake and hypothalamic neuronal activity in rats.
de Ávila C; Chometton S; Lenglos C; Calvez J; Gundlach AL; Timofeeva E
Behav Brain Res; 2018 Jan; 336():135-144. PubMed ID: 28864207
[TBL] [Abstract][Full Text] [Related]
10. Signalling profiles of H3 relaxin, H2 relaxin and R3(BΔ23-27)R/I5 acting at the relaxin family peptide receptor 3 (RXFP3).
Kocan M; Sarwar M; Hossain MA; Wade JD; Summers RJ
Br J Pharmacol; 2014 Jun; 171(11):2827-41. PubMed ID: 24641548
[TBL] [Abstract][Full Text] [Related]
11. Central injection of relaxin-3 receptor (RXFP3) antagonist peptides reduces motivated food seeking and consumption in C57BL/6J mice.
Smith CM; Chua BE; Zhang C; Walker AW; Haidar M; Hawkes D; Shabanpoor F; Hossain MA; Wade JD; Rosengren KJ; Gundlach AL
Behav Brain Res; 2014 Jul; 268():117-26. PubMed ID: 24681162
[TBL] [Abstract][Full Text] [Related]
12. Relaxin-3, INSL5, and their receptors.
Liu C; Lovenberg TW
Results Probl Cell Differ; 2008; 46():213-37. PubMed ID: 18236022
[TBL] [Abstract][Full Text] [Related]
13. Probing the functional domains of relaxin-3 and the creation of a selective antagonist for RXFP3/GPCR135 over relaxin receptor RXFP1/LGR7.
Liu C; Kuei C; Sutton S; Shelton J; Zhu J; Nepomuceno D; Hossain MA; Wade JD; Bathgate RA; Bonaventure P; Lovenberg T
Ann N Y Acad Sci; 2009 Apr; 1160():31-7. PubMed ID: 19416155
[TBL] [Abstract][Full Text] [Related]
14. R3(BDelta23 27)R/I5 chimeric peptide, a selective antagonist for GPCR135 and GPCR142 over relaxin receptor LGR7: in vitro and in vivo characterization.
Kuei C; Sutton S; Bonaventure P; Pudiak C; Shelton J; Zhu J; Nepomuceno D; Wu J; Chen J; Kamme F; Seierstad M; Hack MD; Bathgate RA; Hossain MA; Wade JD; Atack J; Lovenberg TW; Liu C
J Biol Chem; 2007 Aug; 282(35):25425-35. PubMed ID: 17606621
[TBL] [Abstract][Full Text] [Related]
15. Metabolic and neuroendocrine responses to RXFP3 modulation in the central nervous system.
Sutton SW; Shelton J; Smith C; Williams J; Yun S; Motley T; Kuei C; Bonaventure P; Gundlach A; Liu C; Lovenberg T
Ann N Y Acad Sci; 2009 Apr; 1160():242-9. PubMed ID: 19416196
[TBL] [Abstract][Full Text] [Related]
16. Role of relaxin-3/RXFP3 system in stress-induced binge-like eating in female rats.
Calvez J; de Ávila C; Matte LO; Guèvremont G; Gundlach AL; Timofeeva E
Neuropharmacology; 2016 Mar; 102():207-15. PubMed ID: 26607097
[TBL] [Abstract][Full Text] [Related]
17. A convenient method for europium-labeling of a recombinant chimeric relaxin family peptide R3/I5 for receptor-binding assays.
Zhang WJ; Jiang Q; Wang XY; Song G; Shao XX; Guo ZY
J Pept Sci; 2013 Jun; 19(6):350-4. PubMed ID: 23526726
[TBL] [Abstract][Full Text] [Related]
18. Regulation of expression of relaxin-3 and its receptor RXFP3 in the brain of diet-induced obese rats.
Lenglos C; Mitra A; Guèvremont G; Timofeeva E
Neuropeptides; 2014 Jun; 48(3):119-32. PubMed ID: 24629399
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological activation of RXFP3 is not orexigenic in C57BL/6J mice.
Smith CM; Hosken IT; Downer NL; Chua BE; Hossain MA; Wade JD; Gundlach AL
Ital J Anat Embryol; 2013; 118(1 Suppl):52-5. PubMed ID: 24640572
[TBL] [Abstract][Full Text] [Related]
20. Development of a synthetic relaxin-3/INSL5 chimeric peptide ligand for NanoBiT complementation binding assays.
Wu H; Hoare BL; Handley TNG; Akhter Hossain M; Bathgate RAD
Biochem Pharmacol; 2024 Jun; 224():116238. PubMed ID: 38677442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]